Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion – Reuters
- Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters
- Thermo Fisher nears $10bn takeover of drug trial software maker Clario Financial Times
- Thermo Fisher Scientific to acquire Clario Holdings, enabling pharma and biotech customers to accelerate innovation with deeper clinical insights MarketScreener
- Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights Business Wire
- M&A News: Thermo Fisher (TMO) Nears $10B Clario Takeover to Strengthen Clinical Trial Tech TipRanks